BALANCING YOUR PATIENTS' NEEDS
Live / Applied — Third extension granted (statement of use) (as of 21 Nov 2025)
What this means for you
Not registered yet, but its 26 May 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98015888
- Mark type
- Stylized text
- Filed
- 26 May 2023
- Published for opposition
- 26 Mar 2024
- Attorney of record
- Kenneth S. McLaughlin, Jr.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of major depressive disorder; Pharmaceutical preparations for the treatment of bipolar disorder; Pharmaceutical preparations for the treatment of epilepsy; Pharmaceutical preparations for the treatment of schizophrenia; Pharmaceutical preparations for the treatment of migraine headaches; Pharmaceutical preparations for the treatment of neurological diseases and conditions; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders
Owner
- OWP Pharmaceuticals, Inc., Lisle, IL, US
- OWP Pharmaceuticals, Inc., Naperville, IL, US
Prosecution history
- 22 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Nov 2025 — SOU EXTENSION 3 GRANTED
- 21 Nov 2025 — SOU EXTENSION 3 FILED
- 21 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 22 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 May 2025 — SOU EXTENSION 2 GRANTED
- 21 May 2025 — SOU EXTENSION 2 FILED
- 21 May 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Nov 2024 — SOU EXTENSION 1 GRANTED
- 20 Nov 2024 — SOU EXTENSION 1 FILED
- 20 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 21 May 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Mar 2024 — PUBLISHED FOR OPPOSITION